about
Population Pharmacokinetics of Durvalumab in Cancer Patients and Association with Longitudinal Biomarkers of Disease Status.Recent advances in automated protein design and its future challenges.Bispecific antibodies in cancer immunotherapyPharmacometric Applications and Challenges in the Development of Therapeutic Antibodies in Immuno-OncologyExpanding the Boundaries of Biotherapeutics with Bispecific AntibodiesThe use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Pharmacokinetics of Monoclonal Antibodies.
@en
Pharmacokinetics of Monoclonal Antibodies.
@nl
type
label
Pharmacokinetics of Monoclonal Antibodies.
@en
Pharmacokinetics of Monoclonal Antibodies.
@nl
prefLabel
Pharmacokinetics of Monoclonal Antibodies.
@en
Pharmacokinetics of Monoclonal Antibodies.
@nl
P2860
P921
P356
P1476
Pharmacokinetics of Monoclonal Antibodies
@en
P2093
Josiah T Ryman
P2860
P304
P356
10.1002/PSP4.12224
P577
2017-07-29T00:00:00Z